MOLECULAR PROFILE OF METASTATIC COLON CANCER
Journal: Cardiometry
Year: 2023

Metastatic colon cancer (mCC) is a heterogeneous disease, which significantly complicates its prognosis and the choice of an effective treatment strategy for patients. The use of mСС molecular profiling data will allow identifying an optimal approach to justify the choice of therapy and increase the patient’s survival rates.